SBIR/STTR Research Award

SBIR Phase I: Real Time Anesthesia Monitor

Award identifier da39cb5d0b2eab52b33854391567b8995e67cd58c00b92f739c0c3240be22115Awarding agency National Science Foundation

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
AERODYNE RESEARCH INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
HTMHV7AL9A86
Solicitation number
NSF 09-541
Topic code
BC

Research abstract

This Small Business Innovation Research Phase I project proposes to develop a clinical monitor for propofol (2,6-diisopropylphenol), an intravenous anesthetic drug widely used in general surgery and as a sedative agent in the intensive care unit (ICU) because of its favorable safety profile and rapid onset and weaning characteristics. Currently, the effectiveness of propofol-induced anesthesia is only assessed symptomatically. Two independent research groups have recently demonstrated that propofol concentrations in human exhaled breath following intravenous administration are proportional to the blood concentrations. Therefore, pulmonary propofol concentrations could be used as a control variable for closed-loop anesthesia. This Phase I project proposes to study the feasibility of monitoring pulmonary propofol concentrations with a compact and real-time optical device by directly measuring the characteristic spectral features of propofol. The work will focus on a proof-of-principle demonstration and a determination of the ultimate sensitivity of the technique. The possibility of chemical interferences will also be studied. The ability to quantify propofol concentrations reliably and economically could also have broad applications in propofol pharmacokinetics and many clinical investigations. The current technique for monitoring propofol levels in anesthetized patients is by blood samples analysis; a technique that is not only expensive and invasive, but does not provide real-time feedback. If successful, the proposed work will lead to a real time monitor of propofol levels in the bloodstream that could be deployed in hospitals, medical centers and even individual physician offices in order to improve the efficacy of the anesthesia and decrease the risk of sudden patient mortality. Compared to the expensive and bulky proton transfer mass spectrometer, which has been used in research to detect pulmonary propofol, the proposed device is expected to be smaller, less expensive, easier to operate and maintain, and comparable in sensitivity.

Technology keywords

Not reported

Research funding history

410 SBIR/STTR records share this UEI (1983–2025). Reported award amounts total $116,799,166. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Energy, National Aeronautics and Space Administration, National Science Foundation, Environmental Protection Agency, Department of Commerce

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.